---
title: "Obinutuzumab - Chronic Lymphoid Leukemia, Disease - 2"
sidebar: mydoc_sidebar
permalink: db08935-mesh-d015451-2.html
toc: false 
---


Path ID: `DB08935_MESH_D015451_2`
{% include image.html url="images/db08935-mesh-d015451-2.png" file="db08935-mesh-d015451-2.png" alt="db08935-mesh-d015451-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C543332 | Obinutuzumab | Drug |
| GO:0001788 | Antibody-dependent cellular cytotoxicity | BiologicalProcess |
| GO:0001783 | B cell apoptotic process | BiologicalProcess |
| MESH:D015451 | Chronic lymphoid leukemia, disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Obinutuzumab | POSITIVELY REGULATES | Antibody-Dependent Cellular Cytotoxicity |
| Antibody-Dependent Cellular Cytotoxicity | PRECEDES | B Cell Apoptotic Process |
| B Cell Apoptotic Process | NEGATIVELY CORRELATED WITH | Chronic Lymphoid Leukemia, Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08935#BE0000066](https://go.drugbank.com/drugs/DB08935#BE0000066)
